VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV · IEX Real-Time Price · USD
0.630
+0.021 (3.40%)
At close: Apr 18, 2024, 4:00 PM
0.613
-0.017 (-2.68%)
After-hours: Apr 18, 2024, 6:43 PM EDT
VBI Vaccines Market Cap
VBI Vaccines has a market cap or net worth of $17.82 million as of April 18, 2024. Its market cap has decreased by -36.57% in one year.
Market Cap
17.82M
Enterprise Value
47.18M
1-Year Change
-36.57%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since November 21, 2000, VBI Vaccines's market cap has decreased from $110.07B to $17.82M, a decrease of -99.98%. That is a compound annual growth rate of -31.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 17.90M | 3.47% |
Apr 17, 2024 | 17.30M | -1.70% |
Apr 16, 2024 | 17.60M | 28.47% |
Apr 15, 2024 | 13.70M | - |
Apr 12, 2024 | 13.70M | -3.52% |
Apr 11, 2024 | 14.20M | -5.96% |
Apr 10, 2024 | 15.10M | -3.21% |
Apr 9, 2024 | 15.60M | -28.44% |
Apr 8, 2024 | 21.80M | 29.76% |
Apr 5, 2024 | 16.80M | 6.33% |
Apr 4, 2024 | 15.80M | -11.24% |
Apr 3, 2024 | 17.80M | 7.23% |
Apr 2, 2024 | 16.60M | 13.70% |
Apr 1, 2024 | 14.60M | 2.10% |
Mar 28, 2024 | 14.30M | 4.38% |
Mar 27, 2024 | 13.70M | - |
Mar 26, 2024 | 13.70M | 0.74% |
Mar 25, 2024 | 13.60M | - |
Mar 22, 2024 | 13.60M | 1.49% |
Mar 21, 2024 | 13.40M | -1.47% |
Mar 20, 2024 | 13.60M | 2.26% |
Mar 19, 2024 | 13.30M | -1.48% |
Mar 18, 2024 | 13.50M | 1.50% |
Mar 15, 2024 | 13.30M | -5.00% |
Mar 14, 2024 | 14.00M | - |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
STRATA Skin Sciences | 17.53M |
Talphera | 17.48M |
PAVmed | 17.43M |
Minerva Neurosciences | 17.41M |
Orgenesis | 17.22M |
Avalo Therapeutics | 16.91M |
Dominari Holdings | 16.88M |
NeuroBo Pharmaceuticals | 16.76M |